On April 2, 2021 Pfizer Inc. (NYSE: PFE) reported investors and the general public to access a live video webcast of a presentation and conference call with investment analysts at 10 a.m. EDT on Friday, April 9, 2021 (Press release, Pfizer, APR 2, 2021, View Source [SID1234577545]). Pfizer Oncology leadership will provide an update on the Oncology pipeline progress, specifically how the company is applying its capabilities to move quickly and utilize cutting-edge science to key programs such as LORBRENA (lorlatinib) in ALK-positive metastatic lung cancer, elranatamab (PF-06863135) in multiple myeloma and our next generation breast cancer portfolio.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To access the live webcast, including audio, video and presentation slides, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. Participants are advised to register in advance.

Participants will also have an opportunity to ask questions in a live Q&A session with speakers. Those participants who would like to ask a question can dial either (833) 741-0115 in the United States and Canada or (818) 488-5731 outside of the United States and Canada. The password is "Pfizer Oncology".

Visitors to www.pfizer.com/investors will be able to view and listen to an archived copy of the webcast following the conclusion of the event.